TNFα inhibitors (TNFis) have emerged as one of the most effective classes of drugs for inflammatory arthritis, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. This evidence concerns the gene TNF and rheumatoid arthritis.